Ordinary Rebalance | Solactive China Healthcare Disruption Index | Effective Date 1st March 2024
Solactive China Healthcare Disruption Index:
In the ordinary rebalance, effective open 01.03.2024 the following index composition was implemented:
| 3SBIO INC | 0.1653 % |
| AKESO INC | 7.9408 % |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LTD | 7.6301 % |
| ALPHAMAB ONCOLOGY | 0.0635 % |
| CANSINO BIOLOGICS INC | 1.7468 % |
| CHINA MEDICAL SYSTEM HOLDINGS LTD | 0.4135 % |
| CHINA RESOURCES PHARMACEUTICAL | 7.7087 % |
| CSPC PHARMACEUTICAL GROUP LTD | 7.2519 % |
| GENSCRIPT BIOTECH CORP | 8.2996 % |
| GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD | 0.4617 % |
| HANSOH PHARMACEUTICAL GROUP CO | 7.5579 % |
| HUTCHMED CHINA LTD | 0.2765 % |
| INNOVENT BIOLOGICS INC | 8.0588 % |
| JD HEALTH INTERNATIONAL INC | 0.459 % |
| KEYMED BIOSCIENCES INC | 2.3673 % |
| LIVZON PHARMACEUTICAL GROUP INC | 0.4654 % |
| LUYE PHARMA GROUP LTD | 0.1426 % |
| PHARMARON BEIJING CO LTD-H | 0.5174 % |
| REMEGEN CO LTD-H | 0.3714 % |
| SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD | 7.9513 % |
| SHANGHAI JUNSHI BIOSCIENCES CO LTD | 0.4201 % |
| SHANGHAI MICROPORT MEDBOT GR | 3.4155 % |
| SHANGHAI PHARMACEUTICALS HOLDING CO LTD-H | 0.4886 % |
| SIMCERE PHARMACEUTICAL GROUP | 0.1906 % |
| SINO BIOPHARMACEUTICAL LTD ORD | 7.5309 % |
| SKB BIO-B ORD H | 0.1798 % |
| WUXI APPTEC CO LTD | 8.8518 % |
| WUXI BIOLOGICS CAYMAN INC | 8.7641 % |
| YICHANG HEC CHANGJIANG PHA-H | 0.0874 % |
| ZAI LAB LTD | 0.2217 % |